GAITHERSBURG, Md.--(BUSINESS WIRE)--GenVec, Inc. (Nasdaq: GNVC), a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines, announced today that it will have multiple research presentations at the American Society for Gene Therapy 10th Annual Meeting taking place May 30 – June 3 in Seattle, at the Washington State Convention & Trade Center. Ten presentations, including nine by GenVec scientists, will cover advances in GenVec’s core adenovector technology platform and its therapeutic and vaccine programs.
